Insider Transactions in Q3 2022 at Spring Works Therapeutics, Inc. (SWTX)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 12
2022
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
153,897
-1.34%
|
$4,770,807
$31.97 P/Share
|
|
Aug 09
2022
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
69,568
-1.19%
|
$2,574,016
$37.47 P/Share
|
|
Aug 08
2022
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
205,000
-3.4%
|
$7,790,000
$38.33 P/Share
|
|
Jul 18
2022
|
L. Mary Smith Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,551
-0.8%
|
$43,428
$28.47 P/Share
|
|
Jul 18
2022
|
Michael F. Burgess Head of Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
3,103
-5.89%
|
$86,884
$28.47 P/Share
|
|
Jul 14
2022
|
Carlos Alban Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,058
+50.0%
|
-
|